Anya Randle-Colclough
Adult Health · Plantation, FLNPI 1255759759
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.0% of the total across 162 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,874 and has fallen 87.3% since, to $239 in 2025.
Across 162 payments — averaging $21.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$645
- Incyte Corporation$335
- Daiichi Sankyo Inc.$335
- Johnson & Johnson$284
- Eisai Inc.$199
- Takeda Pharmaceuticals U.S.A., Inc.$167
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,27792%
- Education$2848%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 36 | $645 |
| Incyte Corporation | 9 | $335 |
| Daiichi Sankyo Inc. | 7 | $335 |
| Johnson & Johnson | 12 | $284 |
| Eisai Inc. | 15 | $199 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $167 |
| Astellas Pharma US Inc | 8 | $150 |
| Merck | 7 | $131 |
| AbbVie | 7 | $131 |
| Amgen | 8 | $131 |
| Caris MPI, Inc. | 2 | $112 |
| Jazz Pharmaceuticals Inc. | 6 | $92 |
| Pfizer | 6 | $85 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $85 |
| Deciphera Pharmaceuticals Inc. | 3 | $71 |
| Ipsen Biopharmaceuticals, Inc | 3 | $60 |
| E.r. Squibb & Sons, L.L.C. | 3 | $58 |
| Exelixis Inc. | 3 | $57 |
| Myovant Sciences Inc. | 3 | $53 |
| Seagen Inc. | 3 | $48 |
| Sanofi | 2 | $43 |
| AstraZeneca | 2 | $41 |
| Puma Biotechnology, Inc. | 2 | $38 |
| Tempus AI, Inc | 1 | $28 |
| Lilly USA, LLC | 1 | $27 |
| TG Therapeutics, Inc. | 1 | $24 |
| Foundation Medicine, Inc. | 1 | $22 |
| Clovis Oncology, Inc. | 1 | $22 |
| Blueprint Medicines Corporation | 1 | $21 |
| G1 Therapeutics, Inc. | 1 | $20 |
| Bayer | 1 | $20 |
| EMD Serono, Inc. | 1 | $14 |
| Sandoz | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,561 in reported general payments places this provider in the 85th percentile of 2,237 adult health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 13 | $137 |
| Methylprednisolone | 15 | $89 |
| Azithromycin | 18 | $89 |
| Prochlorperazine Maleate | 12 | $81 |
Paid to pharmacies, not to this prescriber.
Other adult health in Plantation
- Patricia PagnottaMaitland$409K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Cynthia OteroMaitland$31K
- Jennifer GodshallTampa$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.